Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · March 02, 2024

Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission

JAMA Cardiology

 

Additional Info

JAMA Cardiology
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial
JAMA Cardiol 2024 Feb 01;9(2)114-124, G Cotter, B Deniau, B Davison, C Edwards, M Adamo, M Arrigo, M Barros, J Biegus, J Celutkiene, K Cerlinskaite-Bajore, O Chioncel, A Cohen-Solal, A Damasceno, R Diaz, G Filippatos, E Gayat, A Kimmoun, CSP Lam, M Metra, M Novosadova, PS Pang, M Pagnesi, P Ponikowski, H Saidu, K Sliwa, K Takagi, JM Ter Maaten, D Tomasoni, A Voors, A Mebazaa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading